Associations between two single nucleotide polymorphismsin the adiponectin gene and polycystic ovary syndrome
Abstract
In the present study we determined whether genetic variability in the gene encoding adiponectin is associated with polycystic ovary syndrome (PCOS). Altogether 143 Caucasian women with PCOS and 245 healthy controls were genotyped for two single nucleotide polymorphisms (SNPs) in exon 2 and intron 2 in the adiponectin gene. Single-point analysis was expanded to pair-of-loci haplotype analysis to examine the estimated haplotype frequencies of the two SNPs, of unknown phase, in the PCOS and control groups. Estimated haplotype frequencies were assessed using the maximum-likelihood method, employing an expectation-maximization algorithm. A significantly different allele distribution in intron 2 SNP was observed between the groups, with the T allele being significantly reduced in the PCOS group (25.9%) compared with the control group (32.7%) ( p = 0.047), at an odds ratio of 0.72 (95% confidence interval 0.52-0.99). Otherwise, the allele and genotype distributions in either SNP were not statistically different between the groups. In haplotype estimation analysis, there was a lower frequency of the haplotype T-T in the PCOS group (25.9%) than in the control group (32.7%) ( p = 0.058). We conclude that polymorphisms of the adiponectin gene may be implicated in individual susceptibility to PCOS.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Adiponectin gene polymorphisms may increase susceptibility to PCOS, as the T allele studied is significantly reduced in PCOS patients compared with controls (OR: 0.72; 95% CI: 0.52 to 0.99; P=0.047).
“A Finnish study suggests that adiponectin gene polymorphisms may increase susceptibility to PCOS as the T allele studied is significantly reduced in PCOS patients compared to controls (odds ratio: 0.72; 95% CI: 0.52 to 0.99; P=0.047) (42).”
From Circulating Adipokine Levels in Nonobese Women with Polycystic Ovary Syndrome and in Nonobese Control Women: A Systematic Review and Meta-Analysis (2021) · cites this paper as [42]
The citation lists haven’t been fetched yet
References 20 · Cited by 30
Research works printed but not linked: 2
- Legro R S, 1999, J Clin Endocrinol Metab, 84, 165
- 10.1210/jc.86.5.1930 · DOI · Paper page
- Authors
- Heinonen, S., Korhonen, S., Helisalmi, S., Koivunen, R., Tapanainen, J., HippelÄInen, M., & Laakso, M.
- Affiliations
- Kuopio University Hospital (FI)
- Department of Neuroscience and Neurology, Kuopio University, Kuopio, Finland
- Oulu University Hospital (FI)
- Corresponding author
- Heinonen, Seppo
- Venue
- Gynecological Endocrinology
- Publisher
- Informa UK Limited
- Published
- 2005-01
- Volume
- 21
- Issue
- 3
- Pages
- 165-169
- ISSN
- 0951-3590 (ISSN-L)
- 1473-0766
- OpenAlex
- W1973767865
- Cited by
- 30
- References
- 20
- Citations by year
- 2022: 2 · 2021: 1 · 2019: 2 · 2018: 2 · 2016: 1 · 2015: 1 · 2014: 1 · 2013: 1 · 2012: 4
- FWCI
- 3.50
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Gynecological Endocrinology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Health Sciences › Medicine › Epidemiology › Adipokines, Inflammation, and Metabolic Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic and Kidney Cyst Diseases
- Keywords
- polycystic ovary syndrome, adiponectin, single nucleotide polymorphisms, genetic susceptibility, haplotype analysis, intron 2 polymorphism, exon 2 polymorphism, white women
- MeSH terms
- DNA, Female, Finland, Humans, Polycystic Ovary Syndrome, Case-Control Studies, Polymerase Chain Reaction, DNA Primers, Polymorphism, Single Nucleotide, White People, Adiponectin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review